BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 19837762)

  • 41. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
    Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
    J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibody.
    Sandström K; Nestor M; Ekberg T; Engström M; Anniko M; Lundqvist H
    Tumour Biol; 2008; 29(3):137-44. PubMed ID: 18612218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.
    Liu N; Li M; Li X; Meng X; Yang G; Zhao S; Yang Y; Ma L; Fu Z; Yu J
    J Nucl Med; 2009 Feb; 50(2):303-8. PubMed ID: 19164239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
    Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
    J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
    Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
    J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    Mendler CT; Gehring T; Wester HJ; Schwaiger M; Skerra A
    J Nucl Med; 2015 Jul; 56(7):1112-8. PubMed ID: 25999431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck.
    Schechter NR; Wendt RE; Yang DJ; Azhdarinia A; Erwin WD; Stachowiak AM; Broemeling LD; Kim EE; Cox JD; Podoloff DA; Ang KK
    J Nucl Med; 2004 Oct; 45(10):1683-7. PubMed ID: 15471833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
    Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
    Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biodistribution and radiation dosimetry of [¹⁸F]-5-fluorouracil.
    Hino-Shishikura A; Suzuki A; Minamimoto R; Shizukuishi K; Oka T; Tateishi U; Sugae S; Ichikawa Y; Horiuchi C; Inoue T
    Appl Radiat Isot; 2013 May; 75():11-7. PubMed ID: 23416442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
    Pandit-Taskar N; O'Donoghue JA; Beylergil V; Lyashchenko S; Ruan S; Solomon SB; Durack JC; Carrasquillo JA; Lefkowitz RA; Gonen M; Lewis JS; Holland JP; Cheal SM; Reuter VE; Osborne JR; Loda MF; Smith-Jones PM; Weber WA; Bander NH; Scher HI; Morris MJ; Larson SM
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2093-105. PubMed ID: 25143071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
    Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
    J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.
    Aerts HJ; Dubois L; Perk L; Vermaelen P; van Dongen GA; Wouters BG; Lambin P
    J Nucl Med; 2009 Jan; 50(1):123-31. PubMed ID: 19091906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human Biodistribution and Radiation Dosimetry of S-11C-Methyl-L-Cysteine Using Whole-Body PET.
    Yao B; Tang C; Tang G; Hu K; Liang X; Shi X; Nie D; Tang X; Yue D
    Clin Nucl Med; 2015 Oct; 40(10):e470-4. PubMed ID: 25742235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP).
    Nakaigawa N; Hasumi H; Utsunomiya D; Yoshida K; Ishiwata Y; Oka T; Hayward C; Makiyama K
    Jpn J Clin Oncol; 2024 Jun; ():. PubMed ID: 38864246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults.
    Kumar A; Muzik O; Chugani D; Chakraborty P; Chugani HT
    J Nucl Med; 2010 Jan; 51(1):139-44. PubMed ID: 20008990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
    Lövqvist A; Lundqvist H; Lubberink M; Tolmachev V; Carlsson J; Sundin A
    Med Phys; 1999 Feb; 26(2):249-58. PubMed ID: 10076983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
    Palm S; Enmon RM; Matei C; Kolbert KS; Xu S; Zanzonico PB; Finn RL; Koutcher JA; Larson SM; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1148-55. PubMed ID: 12843231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.